相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Serum ACE2, Angiotensin II, and Aldosterone Levels Are Unchanged in Patients With COVID-19
Marina Rieder et al.
AMERICAN JOURNAL OF HYPERTENSION (2021)
Renin-Angiotensin-Aldosterone System Inhibitors and COVID-19 Infection or Hospitalization: A Cohort Study
Sascha Dublin et al.
AMERICAN JOURNAL OF HYPERTENSION (2021)
Complement Activation in the Disease Course of Coronavirus Disease 2019 and Its Effects on Clinical Outcomes
Aline H. de Nooijer et al.
JOURNAL OF INFECTIOUS DISEASES (2021)
Antihypertensive Drugs and COVID-19 Risk A Cohort Study of 2 Million Hypertensive Patients
Laura Semenzato et al.
HYPERTENSION (2021)
Endothelial C3a receptor mediates vascular inflammation and blood-brain barrier permeability during aging
Nicholas E. Propson et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
ACE2-Erhohung bei schwerem COVID-19-Verlauf
Annkatrin Wagner
PNEUMOLOGIE (2021)
Soluble ACE2-mediated cell entry of SARS-CoV-2 via interaction with proteins related to the renin-angiotensin system
Man Lung Yeung et al.
CELL (2021)
Leveraging Genetics for Hereditary Angioedema: A Road Map to Precision Medicine
Anastasios E. Germenis et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2021)
Pathways for bradykinin formation and interrelationship with complement as a cause of edematous lung in COVID-19 patients
Allen P. Kaplan et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)
Avacopan for the Treatment of ANCA-Associated Vasculitis
David R. W. Jayne et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Safety and Outcomes Associated with the Pharmacological Inhibition of the Kinin-Kallikrein System in Severe COVID-19
Eli Mansour et al.
VIRUSES-BASEL (2021)
Complement Activation in Kidneys of Patients With COVID-19
Frederick Pfister et al.
FRONTIERS IN IMMUNOLOGY (2021)
The Outcome of Critically Ill COVID-19 Patients Is Linked to Thromboinflammation Dominated by the Kallikrein/Kinin System
Miklos Lipcsey et al.
FRONTIERS IN IMMUNOLOGY (2021)
The fight against COVID-19: Striking a balance in the renin-angiotensin system
Alexis Q. Dean et al.
DRUG DISCOVERY TODAY (2021)
ACE2 Elevation in Severe COVID-19
Roman Reindl-Schwaighofer et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2021)
Counter-regulatory renin-angiotensin system in cardiovascular disease
Maria Paz Ocaranza et al.
NATURE REVIEWS CARDIOLOGY (2020)
Kinin B1 Receptor Is Important in the Pathogenesis of Myeloperoxidase-Specific ANCA GN
Peiqi Hu et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2020)
ACE inhibitor-mediated angioedema
Vincenzo Montinaro et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2020)
Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2
Renhong Yan et al.
SCIENCE (2020)
Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury
Yingxia Liu et al.
SCIENCE CHINA-LIFE SCIENCES (2020)
Proteomic and Metabolomic Characterization of COVID-19 Patient Sera
Bo Shen et al.
CELL (2020)
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann et al.
CELL (2020)
Bradykinin receptors: Agonists, antagonists, expression, signaling, and adaptation to sustained stimulation
Francois Marceau et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2020)
Complement activation in patients with COVID-19: A novel therapeutic target
Massimo Cugno et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)
Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases
Cynthia Magro et al.
TRANSLATIONAL RESEARCH (2020)
Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome
Frank L. van de Veerdonk et al.
ELIFE (2020)
The case of complement activation in COVID-19 multiorgan impact
Marina Noris et al.
KIDNEY INTERNATIONAL (2020)
Endothelial cell infection and endotheliitis in COVID-19
Zsuzsanna Varga et al.
LANCET (2020)
Marked Up-Regulation of ACE2 in Hearts of Patients With Obstructive Hypertrophic Cardiomyopathy: Implications for SARS-CoV-2-Mediated COVID-19
J. Martijn Bos et al.
MAYO CLINIC PROCEEDINGS (2020)
Editorial: Platelets and Immune Responses During Thromboinflammation
Mirta Schattner et al.
FRONTIERS IN IMMUNOLOGY (2020)
Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19
Muthiah Vaduganathan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Hyperinflammation and derangement of renin-angiotensin-aldosterone system in COVID-19: A novel hypothesis for clinically suspected hypercoagulopathy and microvascular immunothrombosis
Brandon Michael Henry et al.
CLINICA CHIMICA ACTA (2020)
Complement in sepsis-when science meets clinics
Tom E. Mollnes et al.
FEBS LETTERS (2020)
C1 esterase inhibitor and the contact system in COVID-19
Timothy M. Thomson et al.
BRITISH JOURNAL OF HAEMATOLOGY (2020)
Complement C5 inhibition in patients with COVID-19-a promising target?
Regis Peffault de Latour et al.
HAEMATOLOGICA (2020)
Endothelial injury and thrombotic microangiopathy in COVID-19: Treatment with the lectin-pathway inhibitor narsoplimab
Alessandro Rambaldi et al.
IMMUNOBIOLOGY (2020)
A mechanistic model and therapeutic interventions for COVID-19 involving a RAS-mediated bradykinin storm
Michael R. Garvin et al.
ELIFE (2020)
Understanding the Pathophysiology of COVID-19: Could the Contact System Be the Key?
Simone Meini et al.
FRONTIERS IN IMMUNOLOGY (2020)
SARS-CoV-2 and ACE2: The biology and clinical data settling the ARB and ACEI controversy
Mina K. Chung et al.
EBIOMEDICINE (2020)
Outcomes Associated With Use of a Kinin B2 Receptor Antagonist Among Patients With COVID-19
Frank L. van de Veerdonk et al.
JAMA NETWORK OPEN (2020)
Platelets Promote Thromboinflammation in SARS-CoV-2 Pneumonia
Francesco Taus et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2020)
Direct activation of the alternative complement pathway by SARS-CoV-2 spike proteins is blocked by factor D inhibition
Jia Yu et al.
BLOOD (2020)
Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Death in Patients Hospitalised with COVID-19: A Retrospective Italian Cohort Study of 43,000 Patients
Gianluca Trifiro et al.
DRUG SAFETY (2020)
Impaired Breakdown of Bradykinin and Its Metabolites as a Possible Cause for Pulmonary Edema in COVID-19 Infection
Steven de Maat et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2020)
Cyclic peptide FXII inhibitor provides safe anticoagulation in a thrombosis model and in artificial lungs
Jonas Wilbs et al.
NATURE COMMUNICATIONS (2020)
Eculizumab treatment for renal failure in a pediatric patient with COVID-19
Ruchi Mahajan et al.
JOURNAL OF NEPHROLOGY (2020)
Novel anti-thrombotic mechanisms mediated by Mas receptor as result of balanced activities between the kallikrein/kinin and the renin-angiotensin systems
Chao Fang et al.
PHARMACOLOGICAL RESEARCH (2020)
Systemic complement activation is associated with respiratory failure in COVID-19 hospitalized patients
Jan C. Holter et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Human recombinant soluble ACE2 in severe COVID-19
Alexander Zoufaly et al.
LANCET RESPIRATORY MEDICINE (2020)
Treatment of COVID-19 With Conestat Alfa, a Regulator of the Complement, Contact Activation and Kallikrein-Kinin System
Pascal Urwyler et al.
FRONTIERS IN IMMUNOLOGY (2020)
Role of Neutrophils in Systemic Vasculitides
Despina Michailidou et al.
FRONTIERS IN IMMUNOLOGY (2020)
Evidence of thrombotic microangiopathy in children with SARS-CoV-2 across the spectrum of clinical presentations
Caroline Diorio et al.
BLOOD ADVANCES (2020)
Anti-C5a antibody IFX-1 (vilobelimab) treatment versus best supportive care for patients with severe COVID-19 (PANAMO): an exploratory, open-label, phase 2 randomised controlled trial
Alexander P. J. Vlaar et al.
LANCET RHEUMATOLOGY (2020)
Complement C3 vs C5 inhibition in severe COVID-19: Early clinical findings reveal differential biological efficacy
Dimitrios C. Mastellos et al.
CLINICAL IMMUNOLOGY (2020)
Renin-Angiotensin-Aldosterone System Inhibitors and Risks of Severe Acute Respiratory Syndrome Coronavirus 2 Infection A Systematic Review and Meta-Analysis
Chieh-Kai Chan et al.
HYPERTENSION (2020)
Eculizumab as an emergency treatment for adult patients with severe COVID-19 in the intensive care unit: A proof-of-concept study
Djillali Annane et al.
ECLINICALMEDICINE (2020)
Angiotensin-(1-7) and Alamandine Promote Anti-inflammatory Response in Macrophages In Vitro and In Vivo
Melissa de Carvalho Santuchi et al.
MEDIATORS OF INFLAMMATION (2019)
C3 glomerulopathy - understanding a rare complement-driven renal disease
Richard J. H. Smith et al.
NATURE REVIEWS NEPHROLOGY (2019)
Long-term stimulation of angiotensin II induced endothelial senescence and dysfunction
Rongxia Li et al.
EXPERIMENTAL GERONTOLOGY (2019)
The Complement Receptor C5aR2: A Powerful Modulator of Innate and Adaptive Immunity
Xaria X. Li et al.
JOURNAL OF IMMUNOLOGY (2019)
The (pro)renin receptor in health and disease
Atsuhiro Ichihara et al.
NATURE REVIEWS NEPHROLOGY (2019)
The Safety and Efficacy of Novel Agents Targeting Factors XI and XII in Early Phase Human Trials
Emma P. DeLoughery et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2019)
MASP-1 Increases Endothelial Permeability
Marta L. Debreczeni et al.
FRONTIERS IN IMMUNOLOGY (2019)
Atypical complement receptor C5aR2 transports C5a to initiate neutrophil adhesion and inflammation
Yoshishige Miyabe et al.
SCIENCE IMMUNOLOGY (2019)
Lanadelumab: A Review in Hereditary Angioedema
Yahiya Y. Syed
DRUGS (2019)
Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction
S. D. Solomon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Novel Therapeutic Approaches Targeting the Renin-Angiotensin System and Associated Peptides in Hypertension and Heart Failure
Lauren B. Arendse et al.
PHARMACOLOGICAL REVIEWS (2019)
Roles of Factor XII in Innate Immunity
Thomas Renne et al.
FRONTIERS IN IMMUNOLOGY (2019)
Blockade of the kallikrein-kinin system reduces endothelial complement activation in vascular inflammation
Ingrid Lopatko Fagerstrom et al.
EBIOMEDICINE (2019)
The C1q Receptors: Focus on gC1qR/p33 (C1qBP, p32, HABP-1)1
Berhane Ghebrehiwet et al.
SEMINARS IN IMMUNOLOGY (2019)
The renin-angiotensin system: going beyond the classical paradigms
Robson Augusto Souza Santos et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2019)
Factor XII - What's important but not commonly thought about
Alvin H. Schmaier et al.
RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2019)
Distinct roles of the anaphylatoxin receptors C3aR, C5aR1 and C5aR2 in experimental meningococcal infections
Marcel Muenstermann et al.
VIRULENCE (2019)
Kinin B1 receptors as a therapeutic target for inflammation
Fatimunnisa Qadri et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2018)
Kallikrein Cleaves C3 and Activates Complement
Sarah Irmscher et al.
JOURNAL OF INNATE IMMUNITY (2018)
Attenuation of pulmonary ACE2 activity impairs inactivation of des-Arg(9) bradykinin/BKB1R axis and facilitates LPS-induced neutrophil infiltration
Chhinder P. Sodhi et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2018)
Coagulation factor XII in thrombosis and inflammation
Coen Maas et al.
BLOOD (2018)
Functional Relevance of the Anaphylatoxin Receptor C3aR for Platelet Function and Arterial Thrombus Formation Marks an Intersection Point Between Innate Immunity and Thrombosis
Reinhard J. Sauter et al.
CIRCULATION (2018)
Deficiency of Complement C3a and C5a Receptors Prevents Angiotensin II-Induced Hypertension via Regulatory T Cells
Xiao-Hui Chen et al.
CIRCULATION RESEARCH (2018)
Angiotensin II Short-Loop Feedback Is There a Role of Ang II for the Regulation of the Renin System In Vivo?
Bjoern Neubauer et al.
HYPERTENSION (2018)
Factor XII and uPAR upregulate neutrophil functions to influence wound healing
Evi X. Stavrou et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Hereditary angioedema: the plasma contact system out of control
S. De Maat et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2018)
Aliskiren inhibits renin-mediated complement activation
Zivile D. Bekassy et al.
KIDNEY INTERNATIONAL (2018)
ANGIOTENSIN II SIGNAL TRANSDUCTION: AN UPDATE ON MECHANISMS OF PHYSIOLOGY AND PATHOPHYSIOLOGY
Steven J. Forrester et al.
PHYSIOLOGICAL REVIEWS (2018)
THE ACE2/ANGIOTENSIN-(1-7)/MAS AXIS OF THE RENIN-ANGIOTENSIN SYSTEM: FOCUS ON ANGIOTENSIN-(1-7)
Robson Augusto Souza Santos et al.
PHYSIOLOGICAL REVIEWS (2018)
Angiotensin-(1-9) reduces cardiovascular and renal inflammation in experimental renin-independent hypertension
Leticia Gonzalez et al.
BIOCHEMICAL PHARMACOLOGY (2018)
Angiotensin IV suppresses inflammation in the brains of rats with chronic cerebral hypoperfusion
Qing-Guang Wang et al.
JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM (2018)
A novel role of renin inhibitor in the complement cascade
Daisuke Nakano et al.
KIDNEY INTERNATIONAL (2018)
Oral Plasma Kallikrein Inhibitor for Prophylaxis in Hereditary Angioedema
E. Aygoeren-Puersuen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Neprilysin Inhibitors and Bradykinin
Duncan J. Campbell
FRONTIERS IN MEDICINE (2018)
Evidence for Heterodimerization and Functional Interaction of the Angiotensin Type 2 Receptor and the Receptor MAS
Julia Leonhardt et al.
HYPERTENSION (2017)
Cl-Inhibitor Decreases the Release of Vasculitis-Like Chemotactic Endothelial Microvesicles
Maria Mossberg et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
Microvesicle transfer of kinin B1-receptors is a novel inflammatory mechanism in vasculitis
Robin Kahn et al.
KIDNEY INTERNATIONAL (2017)
Complement in ANCA-associated vasculitis: mechanisms and implications for management
Min Chen et al.
NATURE REVIEWS NEPHROLOGY (2017)
AT2 receptors in cardiovascular and renal diseases
Elena Kaschina et al.
PHARMACOLOGICAL RESEARCH (2017)
Complement-activation fragment C4a mediates effector functions by binding as untethered agonist to protease-activated receptors 1 and 4
HongBin Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Kallikreins - The melting pot of activity and function
Magdalena Kalinska et al.
BIOCHIMIE (2016)
Role of the ACE2/Angiotensin 1-7 Axis of the Renin-Angiotensin System in Heart Failure
Vaibhav B. Patel et al.
CIRCULATION RESEARCH (2016)
Complement C3 and High Risk of Venous Thromboembolism: 80517 Individuals from the Copenhagen General Population Study
Ina Norgaard et al.
CLINICAL CHEMISTRY (2016)
HAE Pathophysiology and Underlying Mechanisms
Bruce L. Zuraw et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2016)
Cardioprotective Angiotensin-(1-7) Peptide Acts as a Natural-Biased Ligand at the Angiotensin II Type 1 Receptor
Segolene Galandrin et al.
HYPERTENSION (2016)
Heteromerization Between the Bradykinin B2 Receptor and the Angiotensin-(1-7) Mas Receptor: Functional Consequences
Bruno D. Cerrato et al.
HYPERTENSION (2016)
G-Protein-Coupled Receptor MrgD Is a Receptor for Angiotensin-(1-7) Involving Adenylyl Cyclase, cAMP, and Phosphokinase A
Anja Tetzner et al.
HYPERTENSION (2016)
The membrane attack complex as an inflammatory trigger
B. Paul Morgan
IMMUNOBIOLOGY (2016)
A journey through the lectin pathway of complementMBL and beyond
Peter Garred et al.
IMMUNOLOGICAL REVIEWS (2016)
Dangerous liaisons: complement, coagulation, and kallikrein/kinin cross-talk act as a linchpin in the events leading to thromboinflammation
Kristina N. Ekdahl et al.
IMMUNOLOGICAL REVIEWS (2016)
Structure-function relationships in thrombin-activatable fibrinolysis inhibitor
T. Plug et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2016)
Angiotensin IV protects cardiac reperfusion injury by inhibiting apoptosis and inflammation via AT4R in rats
Byung Mun Park et al.
PEPTIDES (2016)
T helper 1 immunity requires complement-driven NLRP3 inflammasome activity in CD4+ T cells
Giuseppina Arbore et al.
SCIENCE (2016)
A comparison of the effects of factor XII deficiency and prekallikrein deficiency on thrombus formation
Yasin Kokoye et al.
THROMBOSIS RESEARCH (2016)
Blocking of Plasma Kallikrein Ameliorates Stroke by Reducing Thromboinflammation
Eva Goeb et al.
ANNALS OF NEUROLOGY (2015)
The polyphosphate-factor XII pathway drives coagulation in prostate cancer-associated thrombosis
Katrin F. Nickel et al.
BLOOD (2015)
A primary role for kinin B1 receptor in inflammation, organ damage, and lethal thrombosis in a rat model of septic shock in diabetes
N. Tidjane et al.
EUROPEAN JOURNAL OF INFLAMMATION (2015)
C4a: An Anaphylatoxin in Name Only
Scott R. Barnum
JOURNAL OF INNATE IMMUNITY (2015)
Novel RAAS agonists and antagonists: clinical applications and controversies
CesarA. Romero et al.
NATURE REVIEWS ENDOCRINOLOGY (2015)
Promotion of Hypercoagulability in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis by C5a-Induced Tissue Factor-Expressing Microparticles and Neutrophil Extracellular Traps
Yi-Min Huang et al.
ARTHRITIS & RHEUMATOLOGY (2015)
Reduced thrombosis in Klkb1-/- mice is mediated by increased Mas receptor, prostacyclin, Sirt1, and KLF4 and decreased tissue factor
Evi X. Stavrou et al.
BLOOD (2015)
Complement 5a Receptor Mediates Angiotensin II-Induced Cardiac Inflammation and Remodeling
Congcong Zhang et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2014)
Neutrophil Extracellular Traps Promote Thrombin Generation Through Platelet-Dependent and Platelet-Independent Mechanisms
Travis J. Gould et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2014)
AT2 Receptor Activation Induces Natriuresis and Lowers Blood Pressure
Brandon A. Kemp et al.
CIRCULATION RESEARCH (2014)
Recent insights and therapeutic perspectives of angiotensin-(1-9) in the cardiovascular system
Maria Paz Ocaranza et al.
CLINICAL SCIENCE (2014)
Angiotensin-(1-12): A Chymase-Mediated Cellular Angiotensin II Substrate
Sarfaraz Ahmad et al.
CURRENT HYPERTENSION REPORTS (2014)
C5a and Bradykinin Receptor Cross-Talk Regulates Innate and Adaptive Immunity in Trypanosoma cruzi Infection
Veronica Schmitz et al.
JOURNAL OF IMMUNOLOGY (2014)
Angiotensin II induced proteolytic cleavage of myocardial ACE2 is mediated by TACE/ADAM-17: A positive feedback mechanism in the RAS
Vaibhav B. Patel et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2014)
A Factor XIIa Inhibitory Antibody Provides Thromboprotection in Extracorporeal Circulation Without Increasing Bleeding Risk
Magnus Larsson et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Primacy of angiotensin converting enzyme in angiotensin-(1-12) metabolism
Norihito Moniwa et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2013)
Angiotensin 1-7 and Mas decrease thrombosis in Bdkrb2-/- mice by increasing NO and prostacyclin to reduce platelet spreading and glycoprotein VI activation
Chao Fang et al.
BLOOD (2013)
Discovery and Characterization of Alamandine A Novel Component of the Renin-Angiotensin System
Roberto Queiroga Lautner et al.
CIRCULATION RESEARCH (2013)
Pharmacokinetics and Pharmacodynamics of Recombinant Human Angiotensin-Converting Enzyme 2 in Healthy Human Subjects
Manuel Haschke et al.
CLINICAL PHARMACOKINETICS (2013)
Contribution of Endogenous Bradykinin to Fibrinolysis, Inflammation, and Blood Product Transfusion Following Cardiac Surgery: A Randomized Clinical Trial
J. M. Balaguer et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2013)
Complement activation in thrombotic microangiopathy
D. Karpman et al.
HAMOSTASEOLOGIE (2013)
Inducible Endothelium-derived Hyperpolarizing Factor: Role of the 15-Lipoxygenase-EDHF Pathway
William B. Campbell et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2013)
Induction of Complement C3a Receptor Responses by Kallikrein-Related Peptidase 14
Katerina Oikonomopoulou et al.
JOURNAL OF IMMUNOLOGY (2013)
Complement Activation Associated with ADAMTS13 Deficiency in Human and Murine Thrombotic Microangiopathy
Ramesh Tati et al.
JOURNAL OF IMMUNOLOGY (2013)
Key developments in renin-angiotensin-aldosterone system inhibition
Bruno Seva Pessoa et al.
NATURE REVIEWS NEPHROLOGY (2013)
Angiotensin III: A physiological relevant peptide of the renin angiotensin system
Vudhya G. Yugandhar et al.
PEPTIDES (2013)
Overview of Complement Activation and Regulation
Marina Noris et al.
SEMINARS IN NEPHROLOGY (2013)
Ecallantide for treatment of acute attacks of hereditary angioedema
Jay L. Martello et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2012)
Angiotensin II increases the permeability and PV-1 expression of endothelial cells
Csaba Bodor et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2012)
Mannose-Binding Lectin-Associated Serine Protease-1 Is a Significant Contributor to Coagulation in a Murine Model of Occlusive Thrombosis
Laura R. La Bonte et al.
JOURNAL OF IMMUNOLOGY (2012)
Endothelium dependent expression and underlying mechanisms of des-Arg9-bradykinin-induced B1R-mediated vasoconstriction in rat portal vein
Fernanda L. Basei et al.
PEPTIDES (2012)
Highly selective hydrolysis of kinins by recombinant prolylcarboxypeptidase
S. M. Chajkowski et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
An Oral Formulation of Angiotensin-(1-7) Produces Cardioprotective Effects in Infarcted and Isoproterenol-Treated Rats
Fulvia D. Marques et al.
HYPERTENSION (2011)
Cross-talk between the complement and the kinin system in vascular permeability
Fleur Bossi et al.
IMMUNOLOGY LETTERS (2011)
Cleavage of Kininogen and Subsequent Bradykinin Release by the Complement Component: Mannose-Binding Lectin-Associated Serine Protease (MASP)-1
Jozsef Dobo et al.
PLOS ONE (2011)
Complement anaphylatoxin C5a contributes to hemodialysis-associated thrombosis
Ioannis Kourtzelis et al.
BLOOD (2010)
Angiotensin II revisited: new roles in inflammation, immunology and aging
Ariela Benigni et al.
EMBO MOLECULAR MEDICINE (2010)
Angiotensin II-Mediated Microvascular Thrombosis
Elena Y. Senchenkova et al.
HYPERTENSION (2010)
Enzymatic pathways in the pathogenesis of hereditary angioedema: The role of C1 inhibitor therapy
Allen P. Kaplan
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)
Inhibition of bradykinin receptor B1 protects mice from focal brain injury by reducing blood-brain barrier leakage and inflammation
Furat Raslan et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2010)
Molecular Intercommunication between the Complement and Coagulation Systems
Umme Amara et al.
JOURNAL OF IMMUNOLOGY (2010)
Blockade of the Kinin B1 Receptor Ameloriates Glomerulonephritis
Julie Klein et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
The plasma bradykinin-forming pathways and its interrelationships with complement
Allen P. Kaplan et al.
MOLECULAR IMMUNOLOGY (2010)
Complement activation on platelets: Implications for vascular inflammation and thrombosis
Ellinor I. Peerschke et al.
MOLECULAR IMMUNOLOGY (2010)
Differential regulation of inducible and endothelial nitric oxide synthase by kinin B1 and B2 receptors
F. Kuhr et al.
NEUROPEPTIDES (2010)
Structures of C3b in Complex with Factors B and D Give Insight into Complement Convertase Formation
Federico Forneris et al.
SCIENCE (2010)
Platelet Polyphosphates Are Proinflammatory and Procoagulant Mediators In Vivo
Felicitas Muller et al.
CELL (2009)
Angiotensin I Is Largely Converted to Angiotensin (1-7) and Angiotensin (2-10) by Isolated Rat Glomeruli
Juan Carlos Q. Velez et al.
HYPERTENSION (2009)
Neutrophil-Derived Proteinase 3 Induces Kallikrein-Independent Release of a Novel Vasoactive Kinin
Robin Kahn et al.
JOURNAL OF IMMUNOLOGY (2009)
Kinin B1 receptor activation turns on exocytosis of matrix metalloprotease-9 and myeloperoxidase in human neutrophils: involvement of mitogen-activated protein kinase family
Pamela Ehrenfeld et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2009)
The role of the anaphylatoxins in health and disease
Andreas Klos et al.
MOLECULAR IMMUNOLOGY (2009)
Blockade of Bradykinin Receptor B1 but Not Bradykinin Receptor B2 Provides Protection From Cerebral Infarction and Brain Edema
Madeleine Austinat et al.
STROKE (2009)
Factor H dysfunction in patients with atypical hemolytic uremic syndrome contributes to complement deposition on platelets and their activation
Anne-Lie Stahl et al.
BLOOD (2008)
Circulating versus tissue renin-angiotensin system: On the origin of (pro)renin
Manne Krop et al.
CURRENT HYPERTENSION REPORTS (2008)
Kinin B2 receptor-mediated bradykinin internalization and metalloendopeptidase EP24.15-dependent intracellular bradykinin degradation
Caroline Sanden et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Deletion of murine kininogen gene 1 (mKng1) causes loss of plasma kininogen and delays thrombosis
Sergei Merkulov et al.
BLOOD (2008)
A novel inflammatory pathway recruitment: Role for the kinin chemokine CXCL5
Johan Duchene et al.
JOURNAL OF IMMUNOLOGY (2007)
Simultaneous Activation of Complement and Coagulation by MBL-Associated Serine Protease 2
Anders Krarup et al.
PLOS ONE (2007)
Classical pathway complement activation on human endothelial cells
Wei Yin et al.
MOLECULAR IMMUNOLOGY (2007)
Mass-spectrometric identification of a novel angiotensin peptide in human plasma
Vera Jankowski et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
The regulation of the inflammatory response through nuclear factor-kappa B pathway by angiotensin IV extends the role of the renin angiotensin system in cardiovascular diseases
Marta Ruiz-Ortega et al.
TRENDS IN CARDIOVASCULAR MEDICINE (2007)
Angiotensin II type 2 receptor-bradykinin B2 receptor functional heterodimerization
Peter M. Abadir et al.
HYPERTENSION (2006)
Activation of kinin B1 receptors induces chemotaxis of human neutrophils
P. Ehrenfeld et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2006)
Generation of C5a in the absence of C3: a new complement activation pathway
Markus Huber-Lang et al.
NATURE MEDICINE (2006)
Platelet activation in hemolytic uremic syndrome
D Karpman et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2006)
Complement activation in angiotensin II - Induced organ damage
E Shagdarsuren et al.
CIRCULATION RESEARCH (2005)
Structure of SARS coronavirus spike receptor-binding domain complexed with receptor
F Li et al.
SCIENCE (2005)
A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury
K Kuba et al.
NATURE MEDICINE (2005)
Angiotensin-converting enzyme 2 protects from severe acute lung failure
Y Imai et al.
NATURE (2005)
Potentiation of des-Arg9-kallidin-induced vasoconstrictor responses by metallopeptidase inhibition in isolated human umbilical artery
FG Pelorosso et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Molecular structure and transcriptional regulation by nuclear factor-κB of the mouse kinin B1 receptor gene
VF Merino et al.
BIOLOGICAL CHEMISTRY (2005)
B1 kinin receptor does not contribute to vascular tone or tissue plasminogen activator release in the peripheral circulation of patients with heart failure
NLM Cruden et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Platelet activation leads to activation and propagation of the complement system
I del Conde et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
International union of pharmacology.: XLV.: Classification of the kinin receptor family:: from molecular mechanisms to pathophysiological consequences
LMF Leeb-Lundberg et al.
PHARMACOLOGICAL REVIEWS (2005)
Mapping the interaction between high molecular mass kininogen and the urokinase plasminogen activator receptor
F Mahdi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Stimulated human neutrophils form biologically active kinin peptides from high and low molecular weight kininogens
M Stuardo et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2004)
Angiotensin II induces neutrophil accumulation in vivo through generation and release of CXC chemokines
YN Abu Nabah et al.
CIRCULATION (2004)
Platelet-activating factor and kinin-dependent vascular leakage as a novel functional activity of the soluble terminal complement complex
F Bossi et al.
JOURNAL OF IMMUNOLOGY (2004)
Pharmacologic demonstration of the synergistic effects of a combination of the renin inhibitor aliskiren and the AT1 receptor antagonist valsartan on the angiotensin II-renin feedback interruption
M Azizi et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2004)
Interaction of high molecular weight kininogen binding proteins on endothelial cells
K Joseph et al.
THROMBOSIS AND HAEMOSTASIS (2004)
Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis
I Hamming et al.
JOURNAL OF PATHOLOGY (2004)
Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism
GI Rice et al.
BIOCHEMICAL JOURNAL (2004)
Angiotensin AT2 receptors directly stimulate renal nitric oxide in bradykinin B2-receptor-null mice
PM Abadir et al.
HYPERTENSION (2003)
Regulation by complement C3a and C5a anaphylatoxins of cytokine production in human umbilical vein endothelial cells
T Monsinjon et al.
FASEB JOURNAL (2003)
Migratory responses of polymorphonuclear leukocytes to kinin peptides
I Paegelow et al.
PHARMACOLOGY (2002)
Immunosuppressive treatment protects against angiotensin II-induced renal damage
DN Muller et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Contact-system activation in children with vasculitis
R Kahn et al.
LANCET (2002)
Complement C3a and C5a induce different signal transduction cascades in endothelial cells
IU Schraufstatter et al.
JOURNAL OF IMMUNOLOGY (2002)
AT1 receptor blockade increases cardiac bradykinin via neutral endopeptidase after induction of myocardial infarction in rats
T Walther et al.
FASEB JOURNAL (2002)
AT2 receptor-dependent vasodilation is mediated by activation of vascular kinin generation under flow conditions
J Katada et al.
BRITISH JOURNAL OF PHARMACOLOGY (2002)
Identification and characterization of prolylcarboxypeptidase as an endothelial cell prekallikrein activator
Z Shariat-Madar et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Angiotensin 1-9 and 1-7 release in human heart -: Role of cathepsin A
HL Jackman et al.
HYPERTENSION (2002)
Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase
C Vickers et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Induction of functional bradykinin B1-receptors in normotensive rats and mice under chronic angiotensin- converting enzyme inhibitor treatment
ME Marin-Castaño et al.
CIRCULATION (2002)
Heat shock protein 90 catalyzes activation of the prekallikrein-kininogen complex in the absence of factor XII
K Joseph et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Angiotensin and vascular fibrinolytic balance
DE Vaughan
AMERICAN JOURNAL OF HYPERTENSION (2002)
Inactivation of C3a and C5a octapeptides by carboxypeptidase R and carboxypeptidase N
WD Campbell et al.
MICROBIOLOGY AND IMMUNOLOGY (2002)
Targeted disruption of the bradykinin B2 receptor gene in mice alters the ontogeny of the renin-angiotensin system
IV Yosipiv et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2001)
The angiotensin II AT2 receptor is an AT1 receptor antagonist
S AbdAlla et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Bradykinin potentiation by angiotensin-(1-7) and ACE inhibitors correlates with ACE C- and N-domain blockade
B Tom et al.
HYPERTENSION (2001)
Diminished cardioprotective response to inhibition of angiotensin-converting enzyme and angiotensin II type 1 receptor in B2 kinin receptor gene knockout mice
XP Yang et al.
CIRCULATION RESEARCH (2001)
High molecular weight kininogen utilizes heparan sulfate proteoglycans for accumulation on endothelial cells
T Renné et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
AT1-receptor heterodimers show enhanced G-protein activation and altered receptor sequestration
S AbdAlla et al.
NATURE (2000)
分享论文
